<DOC>
	<DOCNO>NCT00399256</DOCNO>
	<brief_summary>Background Prevention contrast medium ( CM ) induce nephropathy ( CIN ) pharmacological prophylaxis ( e.g . Nâ€“acetylcysteine ; NAC ) controversially discuss . So far , interventional study assessment kidney function base measurement serum creatinine although surrogate biomarker several limitation . We investigate antioxidant NAC zinc ( Zn ) prevention CIN monitoring concomitantly serum level creatinine cystatin C .</brief_summary>
	<brief_title>Improved Estimation GFR Cystatin C Preventing Contrast Induced Nephropathy NAC Zn</brief_title>
	<detailed_description>In prospective , placebo-controlled , double blind trial patient moderate impaired kidney function receive hypoosmolar , nonionic contrast medium randomly assign oral treatment 2 day 1.2g/day NAC ( n=19 ) , 1 day 60mg/day Zn ( n=18 ) placebo ( n=17 ) . All patient periprocedural hydrate 1ml/kg/h 0.45 % saline 24h . At baseline ( hydration ) , prior exposure CM well 2 6 day CM serum level creatinine cystatin C measure .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<mesh_term>Cystatins</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>1. old 18 year age , 2. serum creatinine &gt; 1.2 mg/dl creatinine clearance &lt; 50 ml/min ( measure 12 24 hour urine collection ) . 1. acute inflammatory disease , 2. medication NSAID metformin 3 day enter study , 3. abnormal finding physical examination , e.g . sign dehydration decompensated heart failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>contrast-induced nephropathy</keyword>
	<keyword>Acetylcysteine</keyword>
	<keyword>Zinc</keyword>
	<keyword>Cystatin C</keyword>
	<keyword>Creatinine</keyword>
</DOC>